Showing results (2141-2150 of 2,175) with videos related to
Sort By:
Pageof 218
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.Journal of Numerical Cognition|November 15, 2021
Next Directions in Measurement of the Home Mathematics Environment: An International and Interdisciplinary PerspectiveCaroline Byrd Hornburg, Giulia A Borriello, Melody Kung, et al.BMJ Open|April 27, 2022
Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)Shamil Haroon, Krishnarajah Nirantharakumar, Sarah E Hughes, et al.Current Oncology (Toronto, Ont.)|August 17, 2018
Eastern Canadian Colorectal Cancer Consensus Conference 2017S F McGee, W AlGhareeb, C H Ahmad, et al.Gastroenterology|August 6, 2016
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome CompositionDalin Li, Jean-Paul Achkar, Talin Haritunians, et al.Lancet (London, England)|October 1, 2020
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trialChristopher C Parker, Noel W Clarke, Adrian D Cook, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolitesFelix S Meier-Stephenson, Vanessa C Meier-Stephenson, Michael D Carter, et al.The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.Journal of Abnormal Psychology|March 24, 2017
The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologiesRoman Kotov, Robert F Krueger, David Watson, et al.The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.Pageof 218